Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure

Circulation: Heart Failure

Volumn 9, Issue 6, 2016, Pages

  Hou, Ning ^a,b   Ye, Bo ^b,c   Li, Xiang ^b   Margulies, Kenneth B ^d   Xu, Haodong ^e   Wang, Xuejun ^f   Li, Faqian ^b,c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

acetylation; cardiomyopathy; cell signaling signal transduction; desmin; heart failure

Indexed keywords

BETA CATENIN; HISTONE H3; MESSENGER RNA; MYC PROTEIN; SHORT HAIRPIN RNA; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; CTNNB1 PROTEIN, MOUSE; DESMIN; MYC PROTEIN, HUMAN; MYC PROTEIN, MOUSE; TCF7L2 PROTEIN, HUMAN; TCF7L2 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HEART FAILURE; HISTONE ACETYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INVESTIGATIVE PROCEDURES; ISCHEMIC HEART DISEASE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BINDING SITE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PROMOTER REGION; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; WNT SIGNALING PATHWAY;

ADULT; ANIMALS; BETA CATENIN; BINDING SITES; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; DESMIN; DISEASE MODELS, ANIMAL; FEMALE; HEART FAILURE; HUMANS; MALE; MICE, KNOCKOUT; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84975831736     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.003010     Document Type: Article

References (42)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011 123 e18 e209. doi: 10.1161/CIR.0b013e3182009701
2. Mann DL, Bristow MR, Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005 111 2837 2849. doi: 10.1161/CIRCULATIONAHA.104.500546
3. Heineke J, Molkentin JD, Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006 7 589 600. doi: 10.1038/nrm1983
4. Chien KR, Knowlton KU, Zhu H, Chien S, Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991 5 3037 3046
5. Izumo S, Nadal-Ginard B, Mahdavi V, Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 1988 85 339 343
6. Komuro I, Kurabayashi M, Takaku F, Yazaki Y, Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 1988 62 1075 1079
7. Ahuja P, Zhao P, Angelis E, Ruan H, Korge P, Olson A, Wang Y, Jin ES, Jeffrey FM, Portman M, Maclellan WR, Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J Clin Invest 2010 120 1494 1505. doi: 10.1172/JCI38331
8. Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, Bu L, Jiang X, Lin L, Granger A, Moretti A, Caron L, Wu X, Clarke J, Taketo MM, Laugwitz KL, Moon RT, Gruber P, Evans SM, Ding S, Chien KR, The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2007 1 165 179. doi: 10.1016/j.stem.2007.05.018
9. Sierra J, Yoshida T, Joazeiro CA, Jones KA, The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 2006 20 586 600. doi: 10.1101/gad.1385806
10. Cohen ED, Wang Z, Lepore JJ, Lu MM, Taketo MM, Epstein DJ, Morrisey EE, Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest 2007 117 1794 1804. doi: 10.1172/JCI31731
11. Linask KK, Knudsen KA, Gui YH, N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. Dev Biol 1997 185 148 164. doi: 10.1006/dbio.1997.8570
12. Zhou J, Qu J, Yi XP, Graber K, Huber L, Wang X, Gerdes AM, Li F, Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 2007 292 H270 H276. doi: 10.1152/ajpheart.00576.2006
13. Willert K, Jones KA, Wnt signaling: is the party in the nucleus? Genes Dev 2006 20 1394 1404. doi: 10.1101/gad.1424006
14. Wang X, Osinska H, Dorn GW II, Nieman M, Lorenz JN, Gerdes AM, Witt S, Kimball T, Gulick J, Robbins J, Mouse model of desmin-related cardiomyopathy. Circulation 2001 103 2402 2407
15. Nguyen H, Merrill BJ, Polak L, Nikolova M, Rendl M, Shaver TM, Pasolli HA, Fuchs E, Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. Nat Genet 2009 41 1068 1075. doi: 10.1038/ng.431
16. Simpson P, McGrath A, Savion S, Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982 51 787 801
17. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T, Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000 151 117 130
18. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klövekorn WP, Schlepper M, Schaper W, Schaper J, Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 2000 86 846 853
19. Wang X, Li F, Campbell SE, Gerdes AM, Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling. J Mol Cell Cardiol 1999 31 319 331. doi: 10.1006/jmcc.1998.0885
20. Oosterwegel M, van de Wetering M, Dooijes D, Klomp L, Winoto A, Georgopoulos K, Meijlink F, Clevers H, Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers. J Exp Med 1991 173 1133 1142
21. Travis A, Amsterdam A, Belanger C, Grosschedl R, LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev 1991 5 880 894
22. Lee YJ, Swencki B, Shoichet S, Shivdasani RA, A possible role for the high mobility group box transcription factor Tcf-4 in vertebrate gut epithelial cell differentiation. J Biol Chem 1999 274 1566 1572
23. Angus-Hill ML, Elbert KM, Hidalgo J, Capecchi MR, T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci USA 2011 108 4914 4919. doi: 10.1073/pnas.1102300108
24. Busk PK, Bartkova J, Strøm CC, Wulf-Andersen L, Hinrichsen R, Christoffersen TE, Latella L, Bartek J, Haunsø S, Sheikh SP, Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 2002 56 64 75
25. Kai H, Muraishi A, Sugiu Y, Nishi H, Seki Y, Kuwahara F, Kimura A, Kato H, Imaizumi T, Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Circ Res 1998 83 594 601
26. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T, Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 2003 100 4610 4615. doi: 10.1073/pnas.0835895100
27. van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC, Wynshaw-Boris A, Smits JF, Blankesteijn WM, Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. Hypertension 2007 49 473 480
28. Chen X, Shevtsov SP, Hsich E, Cui L, Haq S, Aronovitz M, Kerkelä R, Molkentin JD, Liao R, Salomon RN, Patten R, Force T, The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Cell Biol 2006 26 4462 4473. doi: 10.1128/MCB.02157-05
29. Qu J, Zhou J, Yi XP, Dong B, Zheng H, Miller LM, Wang X, Schneider MD, Li F, Cardiac-specific haploinsufficiency of beta-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction. J Mol Cell Cardiol 2007 43 319 326. doi: 10.1016/j.yjmcc.2007.06.006
30. Barandon L, Couffinhal T, Ezan J, Dufourcq P, Costet P, Alzieu P, Leroux L, Moreau C, Dare D, Duplàa C, Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 2003 108 2282 2289. doi: 10.1161/01.CIR.0000093186.22847.4C
31. Zelarayán LC, Noack C, Sekkali B, Kmecova J, Gehrke C, Renger A, Zafiriou MP, van der Nagel R, Dietz R, de Windt LJ, Balligand JL, Bergmann MW, Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci USA 2008 105 19762 19767. doi: 10.1073/pnas.0808393105
32. Hahn JY, Cho HJ, Bae JW, Yuk HS, Kim KI, Park KW, Koo BK, Chae IH, Shin CS, Oh BH, Choi YS, Park YB, Kim HS, Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem 2006 281 30979 30989. doi: 10.1074/jbc.M603916200
33. Baurand A, Zelarayan L, Betney R, Gehrke C, Dunger S, Noack C, Busjahn A, Huelsken J, Taketo MM, Birchmeier W, Dietz R, Bergmann MW, Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res 2007 100 1353 1362. doi: 10.1161/01.RES.0000266605.63681.5a
34. Ye B, Ge Y, Perens G, Hong L, Xu H, Fishbein MC, Li F, Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction. Cardiovasc Pathol 2013 22 54 57. doi: 10.1016/j.carpath.2012.03.004
35. Zhong W, Mao S, Tobis S, Angelis E, Jordan MC, Roos KP, Fishbein MC, de Alborán IM, MacLellan WR, Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J 2006 25 3869 3879. doi: 10.1038/sj.emboj.7601252
36. Dzimiri N, Al-Bahnasi K, Al-Halees Z, Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload. Fundam Clin Pharmacol 2004 18 39 44
37. Taketani S, Sawa Y, Ichikawa H, Ohtake S, Nishimura M, Kawaguchi N, Matsuda H, Change of c-Myc expression and cardiac hypertrophy in patients with aortic valve replacement. Ann Thorac Surg 2001 71 1154 1159
38. Xiao G, Mao S, Baumgarten G, Serrano J, Jordan MC, Roos KP, Fishbein MC, MacLellan WR, Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 2001 89 1122 1129
39. Lee HG, Chen Q, Wolfram JA, Richardson SL, Liner A, Siedlak SL, Zhu X, Ziats NP, Fujioka H, Felsher DW, Castellani RJ, Valencik ML, McDonald JA, Hoit BD, Lesnefsky EJ, Smith MA, Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS One 2009 4 e7172. doi: 10.1371/journal.pone.0007172
40. Kolly C, Zakher A, Strauss C, Suter MM, Müller EJ, Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells. FEBS Lett 2007 581 1969 1976. doi: 10.1016/j.febslet.2007.04.023
41. Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, Ukkonen E, Taipale J, Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 2006 124 47 59. doi: 10.1016/j.cell.2005.10.042
42. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL, The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 1990 10 3709 3716